Abstract
The consumption of cycad (Cycas circinalis) seeds has been linked to the development of Amyotrophic Lateral Sclerosis-Parkinsonism Dementia Complex (ALS-PDC) in humans. ALS-PDC is a clinically variable disease presenting as a combination of symptoms typical of PD and/or ALS. Chronic consumption of β-sitosterol β-D-glucoside (BSSG), a component of the cycad seed, by rats (Rattus norvegicus) has been previously reported to initiate a progressive pathology that develops over several months and manifests as behavioural and histopathological changes that resemble characteristic features of Parkinson’s disease. As part of an independent multi-site validation study, we have tried to replicate and further characterize the BSSG model with a focus on motor function, and associated immunohistochemical markers. Beginning at 3 months of age, male CD® (Sprague Dawley) rats (N = 80) were dosed orally with either a flour pellet or a flour pellet containing BSSG (3 mg) daily (5×/week) for 16 weeks consistent with previous reports of the model. Following BSSG intoxication, separate cohorts of animals (n = 10/treatment) were exposed to a behavioural test battery at 16, 24, 32, or 40 weeks post-initial BSSG feeding. The test battery consisted of the open field test, cylinder test, and ultrasonic vocalization (USV) assessment. No changes in behaviour were observed at any time point. Following behavioural testing, animals were processed for immunohistochemical markers of substantia nigra integrity. Immunohistochemistry of brain tissue revealed no differences in the microglial marker, Iba1, or the dopaminergic integrity marker, tyrosine hydroxylase (TH), in the substantia nigra at any assessment point. The absence of any group differences in behaviour and immunhistochemistry indicates an inability to replicate previous reports. Further investigation into the sources of variability in the model is necessary prior to further utilization of the BSSG model in preclinical studies.
Highlights
Parkinson’s disease (PD) is a progressive neurodegenerative disorder that affects approximately 100,000 Canadians (Gaskin et al, 2017) and 6 million people worldwide (Dorsey et al, 2007; Vos et al, 2017), making it the second most common neurodegenerative disorder following Alzheimer’s Disease (AD) (de Lau and Breteler, 2006)
To determine if BSSG intoxication resulted in any changes in PDrelevant markers of dopaminergic function and inflammation we measured the expression of tyrosine hydroxylase (TH) and Iba1
There were no group differences in behaviour or immunohistochemistry at any of the four assessment points. These findings stand in stark contrast to prior reports of the BSSG model in rats, which revealed progressive onset of motor and cognitive deficits accompanied by significant changes in associated immunohistochemical markers (Van Kampen et al, 2014, 2015)
Summary
Parkinson’s disease (PD) is a progressive neurodegenerative disorder that affects approximately 100,000 Canadians (Gaskin et al, 2017) and 6 million people worldwide (Dorsey et al, 2007; Vos et al, 2017), making it the second most common neurodegenerative disorder following Alzheimer’s Disease (AD) (de Lau and Breteler, 2006). PD is most well-known for its effects on movement; the early motor symptoms include bradykinesia (a paucity and slowness of movement), muscular rigidity and tremor (Moustafa et al, 2016). Motor function is severely impaired, with additional problems related to balance and gait (Boonstra et al, 2008). These disrupted motor functions have additional implications in essential functions such as the production of speech (Tjaden, 2008), among others (Moustafa et al, 2016). There is currently no cure or means of slowing the progression of PD (Stoker et al, 2018)
Sign-in/Register to view highlights & summary Sign-in/Register to access full text options 
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a callDisclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.
